| Year |
Citation |
Score |
| 2022 |
McKimpson WM, Kitsis RN. Inducing and measuring apoptotic cell death in mouse pancreatic β-cells and in isolated islets. Star Protocols. 3: 101287. PMID 35719268 DOI: 10.1016/j.xpro.2022.101287 |
0.565 |
|
| 2021 |
McKimpson WM, Chen Y, Irving JA, Zheng M, Weinberger J, Tan WLW, Tiang Z, Jagger AM, Chua SC, Pessin JE, Foo RS, Lomas DA, Kitsis RN. Conversion of the death inhibitor ARC to a killer activates pancreatic β cell death in diabetes. Developmental Cell. PMID 33667344 DOI: 10.1016/j.devcel.2021.02.011 |
0.564 |
|
| 2020 |
McKimpson WM, Kuo T, Kitamoto T, Higuchi S, Haeusler R, Accili D. SUN-646 A Novel Population of FOXO1-Expressing Cells in the Stomach Controls Cell Plasticity by Regulating the Cyclin CCNE1 Journal of the Endocrine Society. 4. DOI: 10.1210/Jendso/Bvaa046.528 |
0.307 |
|
| 2018 |
MCKIMPSON W, KUO T, ACCILI D. Foxo1-Expressing Cells in the Gut as a Source of Insulin for Diabetes Treatment Diabetes. 67: 324-OR. DOI: 10.2337/Db18-324-Or |
0.405 |
|
| 2017 |
Hazan RB, Suyama K, Yao J, Liang H, Benard O, Loudig OD, Amgalan D, McKimpson WM, Phillips GR, Segall JE, Wang Y, Fineberg S, Norton L, Kitsis RN. An Akt3 splice variant lacking the serine 472 phosphorylation site promotes apoptosis and suppresses mammary tumorigenesis. Cancer Research. PMID 29038347 DOI: 10.1158/0008-5472.Can-15-1462 |
0.545 |
|
| 2017 |
McKimpson WM, Zheng M, Chua SC, Pessin JE, Kitsis RN. ARC is essential for maintaining pancreatic islet structure and β-cell viability during type 2 diabetes. Scientific Reports. 7: 7019. PMID 28765602 DOI: 10.1038/S41598-017-07107-W |
0.577 |
|
| 2017 |
McKimpson WM, Kitsis RN. A New Role for the ER Unfolded Protein Response Mediator ATF6: Induction of a Generalized Antioxidant Program. Circulation Research. 120: 759-761. PMID 28254796 DOI: 10.1161/Circresaha.117.310577 |
0.55 |
|
| 2017 |
Stanley RF, Piszczatowski RT, Bartholdy B, Mitchell K, McKimpson WM, Narayanagari S, Walter D, Todorova TI, Hirsch C, Makishima H, Will B, McMahon C, Gritsman K, Maciejewski JP, Kitsis RN, et al. A myeloid tumor suppressor role for NOL3. The Journal of Experimental Medicine. PMID 28232469 DOI: 10.1084/Jem.20162089 |
0.543 |
|
| 2015 |
McKimpson WM, Yuan Z, Zheng M, Crabtree JS, Libutti SK, Kitsis RN. The Cell Death Inhibitor ARC Is Induced in a Tissue-Specific Manner by Deletion of the Tumor Suppressor Gene Men1, but Not Required for Tumor Development and Growth. Plos One. 10: e0145792. PMID 26709830 DOI: 10.1371/Journal.Pone.0145792 |
0.521 |
|
| 2015 |
Chen H, Ruiz PD, McKimpson WM, Novikov L, Kitsis RN, Gamble MJ. MacroH2A1 and ATM Play Opposing Roles in Paracrine Senescence and the Senescence-Associated Secretory Phenotype. Molecular Cell. 59: 719-31. PMID 26300260 DOI: 10.1016/J.Molcel.2015.07.011 |
0.559 |
|
| 2015 |
Chen H, Ruiz PD, McKimpson W, Novikov L, Kitsis RN, Gamble MJ. Abstract 1267: The senescence-associated secretory phenotype requires the histone variant macroH2A1 and is antagonized by ATM in a novel ER stress response Cancer Research. 75: 1267-1267. DOI: 10.1158/1538-7445.Am2015-1267 |
0.594 |
|
| 2013 |
McKimpson WM, Weinberger J, Czerski L, Zheng M, Crow MT, Pessin JE, Chua SC, Kitsis RN. The apoptosis inhibitor ARC alleviates the ER stress response to promote β-cell survival. Diabetes. 62: 183-93. PMID 22933109 DOI: 10.2337/Db12-0504 |
0.624 |
|
| 2011 |
Kung G, McKimpson W, Kitsis RN. NOL3 (nucleolar protein 3 (apoptosis repressor with CARD domain)) Atlas of Genetics and Cytogenetics in Oncology and Haematology. DOI: 10.4267/2042/44736 |
0.601 |
|
| 2009 |
Prystowsky MB, Adomako A, Smith RV, Kawachi N, McKimpson W, Atadja P, Chen Q, Schlecht NF, Parish JL, Childs G, Belbin TJ. The histone deacetylase inhibitor LBH589 inhibits expression of mitotic genes causing G2/M arrest and cell death in head and neck squamous cell carcinoma cell lines. The Journal of Pathology. 218: 467-77. PMID 19402126 DOI: 10.1002/Path.2554 |
0.397 |
|
| Show low-probability matches. |